Key result
Between 1998 and 2003, age-sex standardized rates of myocardial infarction based on AHA criteria including troponins increased by 17%, whereas rates based on hospital discharge coding decreased by 3.5%.
Why the study?
How does the use of troponin-based diagnostic criteria affect the observed population trends in myocardial infarction admission rates compared to traditional biomarkers or hospital coding?
Cohort (n=18,127)
Yes
How does the use of troponin-based diagnostic criteria affect the observed population trends in myocardial infarction admission rates compared to traditional biomarkers or hospital coding?
The introduction of troponin testing significantly altered the apparent epidemiological trends of myocardial infarction, highlighting the need for standardized diagnostic thresholds in population monitoring.
Answers are grounded in this paper and cite their sources.
Troponin-based MI criteria may unmask rising incidence hidden by coding; leaves open standardized surveillance methods.
BACKGROUND: Troponins (highly sensitive biomarkers of myocardial damage) increase counts of myocardial infarction (MI) in clinical practice, but their impact on trends in admission rates for MI in National statistics is uncertain. METHODS: Cases coded as MI or other cardiac diagnoses in the Hospital Morbidity Data Collection (MI-HMDC) in Western Australia in 1998 and 2003 were classified using revised criteria for MI developed by an International panel convened by the American Heart Association (AHA criteria) using information on symptoms, ECGs and cardiac biomarkers abstracted from samples of medical notes. Age-sex standardized rates of MI-HMDC were compared with rates of MI based on AHA criteria including troponins (MI-AHA) or traditional biomarkers only (MI-AHAck). RESULTS: Between 1998 and 2003, rates of MI-HMDC decreased by 3.5% whereas rates of MI-AHA increased by 17%, a difference largely due to increased false-negative cases in the HMDC associated with marked increased use of troponin tests in cardiac admissions generally, and progressively lower test thresholds. In contrast, rates of MI-AHAck declined by 18%. CONCLUSIONS: Increasing misclassification of MI-AHA by the HMDC may be due to reluctance by clinicians to diagnose MI based on relatively small increases in troponin levels. These influences are likely to continue. Monitoring MI using AHA criteria will require calibration of commercially available troponin tests and agreement on lower diagnostic thresholds for epidemiological studies. Declining rates of MI-AHA ck are consistent with long-standing trends in MI in Western Australia, suggesting that neither MI-HMDC nor MI-AHA reflect the true underlying population trends in MI.
No takes yet. Share an insight, caveat, or question.
Sanfilippo et al. (2011) conducted a cohort in Myocardial infarction (n=18,127). AHA criteria including troponins (MI-AHA) vs. Hospital Morbidity Data Collection coding (MI-HMDC) was evaluated on Change in age-sex standardized rates of admission for non-fatal MI between 1998 and 2003. Between 1998 and 2003, age-sex standardized rates of myocardial infarction based on AHA criteria including troponins increased by 17%, whereas rates based on hospital discharge coding decreased by 3.5%.
Synapse has enriched 10 related papers. Consider them for comparative context: